Research: Clorox Company
Click here to sign up for a Caris Research Account
8/10/2010
(CLX) CLX (Caris Update) Maintaining FY11E EPS and $67 Price Target
No introduction text is currently available for this report.
5/04/2010
(CLX) CLX (Caris Price Target Change) Cutting FY11E EPS Due to Higher Commodity Costs, Old: $68, New: $67
No introduction text is currently available for this report.
2/08/2010
(CLX) CLX (Caris Price Target Change)-Gross Margin and Op. Profit Declines Projected for 2H10; PT to $68
No introduction text is currently available for this report.
11/09/2009
(CLX) CLX-Swine Flu Boosts Results, But Competition Intensifies, Old: $65, New: $67
No introduction text is currently available for this report.
8/04/2009
(CLX) CLX-Cutting FY10E EPS But Raising Price Target to $65
No introduction text is currently available for this report.
6/12/2009
(CLX) CLX-Reducing Fiscal 1H10E EPS by $0.15
No introduction text is currently available for this report.
6/09/2009
(CLX) CLX-Two-Year Report Card: An “A” on Some Metrics, But Room for Improvement on Others
No introduction text is currently available for this report.
5/04/2009
(CLX) CLX-Trimming FY10E EPS But Maintaining $61 Price Target
No introduction text is currently available for this report.
2/09/2009
(CLX) CLX-Maintaining FY09E EPS and $61 Price Target
No introduction text is currently available for this report.
12/11/2008
(CLX) CL-Upgrade to 1*/Buy—Pricing, Productivity and Lower Commodities Should More Than Offset FX in 2009
No introduction text is currently available for this report.
Depending on the investment objectives and financial information specific to your situation, the investments discussed or recommended on this website may or may not be suitable for you. It is your responsibility to consider any investment decision carefully. The information contained on this website should not be construed as advice designed to meet the particular needs of any investor. Past performance is not necessarily indicative of future performance, and does not guarantee future results. The price and/or value of any security noted directly or indirectly on this website may fluctuate adversely to your interests, and/or those of other investors. Caris & Company accepts no liability whatsoever for loss or damage of any sort arising out of use of all or part of any information on this website.